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The EBNA-LP protein encoded by the open reading frame in the leader exons of the Epstein–Barr nuclear antigen
messages is essential for efficient immortalization of B lymphocytes. Protein–protein interaction studies using affinity
precipitation of proteins from [35S]methionine-labeled cell lysates and bacterially expressed maltose binding protein EBNA-
LP fusions were performed. A cellular 68/72-kDa doublet protein was detected. This banding pattern was shown to be
identical to that obtained in affinity precipitations with fusions of glutathione–S-transferase and Sp1 (a basal transcription
factor). For both EBNA-LP and Sp1 the specific interacting cellular proteins have been identified as heat shock proteins
(HSP) 72/73. Affinity precipitation of HSP 72/73 with deletion mutants of EBNA-LP maps the interaction domain on EBNA-
LP to exon Y2 which is required for immortalization. Immunoprecipitation of EBNA-LP from EBV-positive lymphoblastoid
cell lines coprecipitated the HSP 72/73 proteins, indicating that the interaction occurs in vivo as well as in vitro. The
association of HSPs with a widening range of nuclear proteins involved in gene expression and proliferation control now
includes Sp1 and EBNA-LP and suggests that there is a central role for molecular chaperones in these processes. q 1996
Academic Press, Inc.
INTRODUCTION Kieff, 1990). Cellular genes for the B cell activation mark-
ers CD21 and CD23 and the oncogene c-fgr are alsoEBV infects and immortalizes B lymphocytes (Leibow-
activated in EBNA2 expressing cells (Cordier-Bussat etitz and Kieff, 1990; Klein, 1994; Thorley-Lawson and
al., 1993). EBNA1 is a viral origin of replication (ori P)Mann, 1985). Although most infections are resolved by
binding protein which is essential for maintenance of thecell-mediated immune responses under certain condi-
viral episome in proliferating cells (Rawlins et al., 1985).tions EBV immortalized B cells can progress to a malig-
The roles of the other proteins in the immortalizationnant lymphoma (Khanna et al., 1995; Klein, 1983; Penn
process (EBNA3B, EBNA-LP, and LMP2) are not wellet al., 1969). Genetic analyses of the virus have demon-
characterized.strated roles for several viral genes (LMP1, EBNA1, 2,
The open reading frame for EBNA-LP is located in3A, 3C, and 4) in the immortalization process (Robertson
the leader exons of the spliced mRNAs of the EBNAand Kieff, 1995). LMP1 (latent membrane protein 1) is an
transcription unit. It is derived from the repeating W1 andintegral membrane protein and may be a growth factor
W2 exons of the major internal repeat (IR-1) and thereceptor but certainly plays some role in signal transduc-
COOH terminal Y1 and Y2 exons. The length of the W1W2tion since it interacts with TRAF1 (tumor necrosis factor
reiteration varies in different cDNAs and leads to expres-receptor associated factor 1) and LAP1 (LMP associated
sion of a series of related protein species in virus-in-protein 1), a RING-finger-motif-bearing protein with con-
fected cells. The minimal EBNA-LP polypeptide with onlysiderable homology to TRAF2 (Mosialos et al., 1995).
one repeat would be 110 residues in length and richEBNA2 and 3C are transcriptional activators (Marshall
and Sample, 1995; Tsui and Schubach, 1994). EBNA2, in argenines (19 residues) and prolines (18 residues).
in particular, activates expression of the other EBNAs, Recombinant viruses lacking Y1 and Y2 exons are defec-
including EBNA3C and the LMP1 protein by activating tive, but not entirely deficient, in the immortalization phe-
EBNA2 response elements in the upstream regions of notype (Mannick et al., 1991; Hammerschmidt and Sug-
responsive promoters. EBNA2 can be found complexed den, 1989). Immortalization efficiency is reduced 10-fold
with a cellular protein RBP-JK at the conserved core se- and requires the presence of fibroblast feeder layers.
quence of the EBNA2 response elements (Zimber-Strobl Immortalized cells grow slowly with an atypical small
et al., 1994; Ling et al., 1993; Matsunami et al., 1989; rounded appearance. With passage in culture cells even-
Henkel et al., 1994; Waltzer et al., 1994; Leibowitz and tually achieve lymphoblastoid features and feeder layer
independence; however, most colonies do not give rise
to long-term lymphoblastoid cell lines.1 To whom reprint requests should be addressed.
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EBNA-LP has been reported to colocalize by immuno- mycin per milliliter (Gibco BRL, Gaithersburg, MD) and
10% fetal bovine serum (Atlanta Biologicals, Norcross,fluorescence in the nucleus of infected cells with Rb (the
retinoblastoma susceptibility gene product) (Jiang et al., GA). The lymphocytic cell lines were grown in RPMI 1640
with Glutamax (Gibco BRL) supplemented with 100 IU1991). In addition, Rb and the tumor suppressor p53 were
both found to bind to EBNA-LP in in vitro binding experi- penicillin, 100 mg streptomycin per milliliter, and 10% fetal
bovine serum. All cells were grown at 377 in a humidifiedments. The region of EBNA-LP involved in binding was
the argenine-rich segment encoded by the W1 exon of 5% CO2 atmosphere.
the repeating W1W2 domain (Szekely et al., 1993). These
findings have led to the suggestion that EBNA-LP func- Antibodies
tion may be analogous to that of nuclear oncogene pro-
teins encoded by other viruses and involve impairment The monoclonal clone PMG3-245 directed against Rb
and against clone M58 adenovirus type 5 E1a as well asof Rb and p53. Recently, however, it was shown that
immortalized lymphoblasts treated with DNA damaging rabbit anti-mouse IgG1 were obtained from Pharmingen
(San Diego, CA). The monoclonal antibody to the EBNA-agents are capable of undergoing p53-mediated
apoptosis, indicating that p53 function is not neutralized LP protein, JF186 (Finke et al., 1987), was kindly provided
by M. Rowe (University of Birmingham, UK). The mouseby the expression of EBNA-LP (Allday et al., 1995).
Previous work has focused attention on cell-cycle-re- monoclonal antibody clone N27F3-4 specific for constitu-
tive and inducible forms of Hsp 70 (Hsc 73 and Hsplated effects of EBNA-LP expression (Allan et al., 1992).
Along with EBNA2, it is the first viral gene product de- 72) and rat monoclonal antibody clone 1B5 specific for
constitutive Hsc 73 as well as purified recombinant hu-tected upon primary infection of resting lymphoblasts and
EBNA-LP mutant virus immortalized cells show delayed man Hsp 70 protein were obtained from Stress-Gen Bio-
technologies (Victoria, BC, Canada). The polyclonal anti-transit through the G1 phase of the cell cycle. Resting B
cells, primed by CD21 crosslinking with the gp340 virus body to maltose binding protein (MBP) was obtained from
New England Biolabs (Beverly, MA). Rabbit anti-rat IgGenvelope protein to mimic virus infection and transfected
with EBNA2 and EBNA-LP expression vectors, enter and was obtained from Sigma (St. Louis, MO).
progress through the cell cycle as evidenced by synthe-
sis of cyclin D2 (Sinclair et al., 1994). The conclusion Plasmids
of these studies is that EBNA2 and EBNA-LP are key
regulators of cyclin D2 expression and that these two The pGEX-2T plasmid encloding the leader sequences
of glutathione–S-transferase (GST) (Pharmacia, Piscata-viral proteins cooperate to induce a G0 to G1 transition.
In this report we have examined the ability of EBNA- way, NJ) was a gift from P. Robbins (University of Pitts-
burgh). The GST–Rb plasmid containing GST fused to aLP to interact with cellular proteins in extracts of cells
metabolically labeled with [35S]methionine. A p68 72-kDa fragment corresponding to amino acids 379–928 of wild-
type Rb were provided by W. Kaelin (Dana Farber Cancerdoublet interacting species was detected and has subse-
quently been identified as human heat shock protein Institute). The pGEX-E1a plasmid carrying GST fused in
frame to the E1a gene was provided by P. Branton (McGill(HSP). The same proteins are also shown to interact
with the basal transcription factor Sp1 and, as previously University, Montreal, Canada). The GST–SP1a plasmid
containing GST fused to the SP1 gene was a gift from J.reported, the Rb retinoblastoma gene product (Nihei et
al., 1993). The domains of EBNA-LP required for immor- Horowitz (Duke University). The plasmid pMAL-cRI which
encodes an MBP–b-galactosidase fusion protein (MBP–talization are also responsible for HSP interaction.
lacZ) was purchased from New England Biolabs. The
plasmid pMBP was constructed by inserting a stop co-MATERIALS AND METHODS
don downstream of the ma/E gene on pMAL-cRI, thereby
Cells
inhibiting expression of lacZ. Plasmids encoding the
MBP fused to a one-repeat EBNA-LP (pMBP-W1W2Y1Y2)X50-7 cells are human cord lymphocytes immortalized
in vitro and express only the genes for EBNAs and LMPs or various fragments of EBNA-LP (pMBP-W1, pMBP-
W1W2, pMBP-W1W2Y1, pMBP-W2Y1Y2, pMBP-Y1Y2,(Wilson and Miller, 1979). IARC/BL36 is an EBV-positive
Burkitt’s lymphoma cell line kindly provided by G. Lenoir and pMBP-Y2) were obtained by PCR amplification of a
one-repeat EBNA-LP cDNA clone, pSp64-WY1 (derived(Lenoir et al., 1985). DG-75 cells are an EBV-negative
Burkitt’s lymphoma cell line (Ben-Basset et al., 1977) mor- from pIB4WY kindly provided by S. Speck, St. Louis). Each
5* amplimer contained an EcoRI site and each 3* ampli-phologically similar to EBV immortalized B cells. 293 cells
are a human embryonic kidney cell line transformed by mer contained either a BamHI site or an XbaI site such
that the resulting PCR product, upon digestion with theadenovirus DNA and expressing E1A and E1B gene prod-
ucts (Graham et al., 1977). 293 cells were grown in Dul- EcoRI and BamHI or EcoRI and XbaI, could be ligated in
frame downstream of the malE gene of pMAL-cRI. Allbecco’s modified Eagle’s medium supplemented with 2
mM glutamine, 100 IU of penicillin, and 100 mg of strepto- clones were verified by restriction mapping and DNA
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sequencing using a Sequenase 2.0 kit (U.S. Biochemical (TBS) [25 mM Tris – Cl (pH 8.0), 150 mM NaCl]. The
cells were resuspended in methionine-free RPMI at 1Corp.) using the protocol suggested by the manufacturer.
1 107 cells/ml and incubated at 377 for 1 hr. The me-
Preparation of bacterial fusion proteins dium was supplemented with a mixture of [35S]-
methionine and [35S]cysteine (100 mCi/ml medium:
MBP and glutathione–S-transferase fusion protein ex-
Tran 35S-label, 100 Ci/mmol, ICN Biomedicals, Inc.), 1
pression and purification were essentially as described
mM glutamine, and 5% dialyzed fetal bovine serum.
by Smith and Johnson (1988). For preparation of fusion
The cells were incubated for 4 hr and then harvested
proteins to be used as substrates in affinity precipitation
by centrifugation, washed twice with ice-cold TBS, and
experiments, overnight cultures of Escherichia coli (IN-
lysed for 1 – 2 hr in ice-cold EBC buffer [50 mM Tris –
VaF*; Invitrogen) transformed with plasmid DNA were
Cl (pH 8.0), 120 mM NaCl, 0.5% NP-40, 10 mM NaF,
diluted 1:10 in Luria–Bertani medium (LB) containing am-
200 mM sodium orthovanadate] containing 10 mg/ml of
picillin (100 mg/ml) and incubated at 377 for 2 hr. Fusion
the protease inhibitors aprotinin, phenylmethylsulfonyl
proteins were induced by addition of 0.2 mM isopropyl-
fluoride, and leupeptin. The lysates were cleared by
thioglycoside (IPTG) to the culture for 3 hr after which
centrifugation at 14,000 g for 15 min at 47.
cells were recovered by centrifugation (5000 g for 15
min) at 47 and lysed on ice by sonication with two 30- Affinity precipitation and in vitro binding assay
sec pulses in a 1/10 volume of NETN buffer [20 mM Tris –
Cl (pH 8.0), 100 mM NaCl, 1 mM EDTA, 0.5% NP-40]. The GST fusion proteins were expressed in bacteria and
recovered on gluathione beads. MBP fusion proteinssuspension was cleared by centrifugation at 12,000 g for
15 min at 47. Cleared lysates were mixed with either 50 were expressed and recovered on amylose agarose
beads. The beads loaded with fusion proteins wereml glutathione–Sepharose 4B (Pharmacia, Piscataway,
NJ) or amylose agarose (New England Biolabs) per 1 ml rocked with aliquots of precleared whole-cell lysates rep-
resenting 51 106 cells. Lysates were precleared by incu-of lysate and incubated for 1 hr at 47. Beads were washed
three times with NETN buffer and blocked with NETN bating with either glutathione–Sepharose preloaded with
the GST protein or amylose–agarose preloaded with thecontaining 5% nonfat milk. For analysis of concentration
and purity of bound proteins, beads were boiled in 21 MBP protein for 1 hr at 47. After 1 hr of affinity binding
of cell proteins from the lysate the beads were washedSDS sample buffer and loaded onto SDS–polyacrylamide
gels. Proteins were visualized by Coomassie blue stain- three times with NETN and resuspended in 21 SDS sam-
ple buffer [0.625 M Tris (pH 6.8), 2% SDS, 0.15 2-mercap-ing in comparison to protein standards of known concen-
tration. toethanol, 10% glycerol, 0.02 mM bromphenol blue] and
boiled. Bead-bound proteins were resolved by SDS–Large-scale preparation of purified MBP–W1W2Y1Y2
for in vitro binding assays was essentially as described PAGE and visualized by fluorography or immunoblotting.
EN3HANCE (Dupont) was used as a secondary fluor toby the protocol of New England Biolabs. Cells trans-
formed with pMBPW1W2Y1Y2 were grown in 1 liter of increase sensitivity.
Direct binding of purified human recombinant Hsp 70LB medium containing 0.2% glucose and 100 mg/ml ampi-
cillin to an optical density at 600 nm of 0.6. IPTG was (Stress-Gen Biotechnologies) to MBP–EBNA-LP fusion
proteins and MBP–W1W2Y1Y2 to GST–Rb was per-added to a final concentration of 0.3 mM. After 2 hr at
377, the cells were harvested by centrifugation, and the formed in NTN buffer (NETN buffer without EDTA). Puri-
fied Hsp 70 (2 mg) and MBP–W1W2Y1Y2 (5 mg) in 250 mlpellet was resuspended in 50 ml of column buffer [20
mM Tris–Cl (pH 7.4), 200 mM NaCl, 1 mM EDTA]. The NTN were combined with 50 ml of bead-bound unblocked
MBP–EBNA-LP fusion protein derivatives or GST– Rbsuspension was sonicated at 47 for five cycles of 1 min
each and then centrifuged at 12,000 g for 15 min at 47. and incubated at 47 for 2 hr with rocking. The beads were
washed three times with NTN, denatured in gel sampleThe cleared supernatant was loaded onto a 5-ml column
of amylose resin (New England Biolabs) equilibrated in buffer, and separated by SDS–PAGE. Bound proteins
were detected by immunoblotting with the appropriatecolumn buffer and washed with 10 column volumes of
column buffer. The purified protein was eluted with col- antibody.
umn buffer / 10 mM maltose, and fractions were ana-
Immunoprecipitation and immunoblottinglyzed by SDS–PAGE followed by Coomassie staining.
Extracts from the equivalent of 21 107 cells were twiceMetabolic labeling and cell lysis
precleared for 1 hr each time with protein A–Sepharose
beads (Sigma) equilibrated in NETN. Precleared super-Metabolic labeling was essentially as described by
Kaelin et al. (1991). Exponentially growing DG-75 cells natants were used for immunoprecipitation overnight at
47 with protein A–Sepharose beads precoated with satu-were fed fresh media 12 – 18 hr prior to radioisotopic
labeling. The following day, cells were pelleted by cen- rating amounts of the indicated antibodies. When mAbs
were used, protein A–Sepharose was loaded with rabbittrifugation and washed once with Tris-buffered saline
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anti-mouse IgG1 (Pharmingen) or rabbit anti-rat IgG
(Sigma) to provide an isotype-specific affinity matrix. De-
natured immune complexes were separated by electro-
phoresis, transferred to Immobilin PVDF membranes
(Millipore, Bedford, MA), and blocked with Tris–saline
(10 mM Tris, pH 8.0, 150 mM NaCl) containing 5% nonfat
milk. Monoclonal and polyclonal antibodies at appro-
priate dilutions were reacted at 47 from 4 hr to overnight.
Goat a-mouse 125I (ICN Biomedicals, Inc., 2–15 mCi/mg)
or protein A 125I (ICN Biomedicals, Inc., 70–100 mCi/mg)
was used to visualize sites of antibody binding. Detection
of EBNA-LP–Hsp complexes was achieved by immuno-
precipitation with one antiserum (e.g., anti-EBNA-LP) and
immunoblotting with antisera to the other (e.g., anti-Hsp)
or vice versa.
RESULTS
Affinity precipitation of 35S-labeled proteins from
lymphocytes
The EBNA-LP protein is probably similar to other viral
nuclear oncoproteins in that it affects cell growth by mak-
ing physical associations with cellular proteins. In other
systems these interactions have been initially studied by
affinity precipitation using bacterial fusion proteins as
lures (Kaelin et al., 1991). We constructed a series of
MBP fusions containing one to seven W1W2 repeats and
Y1 and Y2 exons for these experiments. Fusions con-
taining more than two repeats were highly unstable and
degraded during synthesis in bacteria (not shown). Even
two repeat containing fusion proteins were not recover-
able in high yield; therefore, most of the affinity precipita-
tion studies have been done with the more stable one
repeat containing fusion proteins. The contribution of
multiple copies of repeats to affinity binding of cellular
FIG. 1. Affinity binding of 35S-labeled cellular proteins from the EBV-proteins cannot be addressed with bacterially expressed negative BL cell line DG-75 to bacterial fusion proteins. Purified maltose
fusion proteins. binding proteins (MBP) or MBP fused to the minimal coding sequence
The undifferentiated EBV-negative B lymphoma cell for EBNA-LP were attached to amylose beads and used as lures for
protein–protein interactions.line DG75 was labeled with [35S]methionine for 4 hr and
a whole cell lysate was prepared. After clarification by
low-speed centrifugation to remove insoluble debris, the
localization or greatly enhanced recovery of interactinglysate was precleared by incubation with MBP bound to
proteins from different cellular compartments. The closeamylose–agarose beads to remove nonspecific binding
migration rates of the two proteins and the variation inproteins. Aliquots of precleared lysate were then incu-
relative intensity suggested that these may be isoformsbated with amylose beads loaded with MBP or MBP –
of the same polypeptide product. Occasionally a proteinW1W2Y1Y2. Eluted cellular proteins were separated on
of 105 kDa molecular weight was also detected, but onlypolyacrylamide gels and detected by autoradiography.
with eluates subjected to no washes or one wash withAfter rinsing unbound or loosely bound cellular proteins
very mild (detergentless) conditions. Suspecting that thisaway, specific binding proteins were eluted with 10 mM
was the previously reported Rb association, affinity pre-maltose. Two proteins initially designated p68 and p72
cipitates of this type were immunoblotted and probed forbased on their apparent molecular weights were specifi-
the presence of Rb (Szekely et al., 1993). The Rb proteincally bound to EBNA-LP fusions (Fig. 1). In different ex-
was never detected in these or any of our affinity precipi-periments the p68 species often appeared to be the more
tation experiments which have included cell fractionationintense species. In cell fractionation studies there was
procedures and variation of binding conditions (pH anda marked tendency to find more protein in nuclear pellets
than cytoplasmic extracts; however, there was no clear mono- and divalent cation concentrations).
AID VY 7927 / 6a17$$$222 04-30-96 22:38:52 vira AP: Virology
95EBNA-LP INTERACTS WITH HSP73
EBNA-LP affinity precipitated protein. An earlier report by
Kaelin et al. (1991) had described a similar size doublet
species interacting with Rb. Recently this doublet was
identified as HSP72/73 (Nihei et al., 1993). Antibodies
against human HSP73 were tested by Western blotting
and reacted with the protein affinity precipitated by Sp1
and EBNA-LP (Fig. 2B). Since no other bands appeared
and the affinity precipitates with GST and MBP bacterial
proteins contained no reactive species, we concluded
that both Sp1 and EBNA-LP specifically interact with HSP
proteins.
To map the location of domains within EBNA-LP re-
sponsible for the interaction with HSP72/73, fusion pro-
teins composed of MBP fused to N-terminal and C-termi-
nal deletions of EBNA-LP open reading frame were con-
structed (Fig. 3). The deletion sites corresponded to the
exon structure (W1W2Y1Y2) of the EBNA-LP gene and
hence deletion mutants were made which contained pro-
gressively fewer exons on the N or C terminus. The pro-
teins with C-terminal deletions proved to be unstable in
bacteria. After screening a panel of protein expressing
FIG. 2. Comparison of MBP– EBNA-LP fusion affinity precipitated p68
clones and using short-time induction procedures, wewith the proteins associated with glutathione–S-transferase (GST) or
were able to obtain pure W1W2 and W1 fusions in suffi-GST –Sp1 fusions. (A) Beads coated with fusion proteins were used to
affinity precipitate 35S-labeled proteins from DG75 cell extracts. (B) cient quantities to perform affinity assays. The W1W2Y1
Cellular proteins affinity precipitated by the fusion proteins were blotted fusion protein degraded too rapidly to be purified in suffi-
and probed with an antibody which recognizes human HSP72/73 heat cient quantities for these analyses. The ability of the mu-
shock proteins.
tants to work in affinity precipitation was analyzed using
purified HSP72/73. Affinity precipitated proteins were im-
munoblotted and probed with anti-HSP73. Only fusionA similar pair of proteins binds to the basal
proteins containing the Y2 exon precipitated the HSP73transcription factor Sp1
protein (Fig. 3C). The Y2 exon consists of only 34 amino
At approximately the same time as these experiments acid residues, representing 31% of the total unique se-
were being performed, a similar doublet banding pattern quence of the protein.
with the lower band often being more intense was also
discovered in affinity precipitates with GST–Sp1 fusion
EBNA-LP interacts with HSP73 in vivoproteins (John Horowitz, Duke University, personal com-
munication). To determine if there was any correspon- Identifying potential interacting species with fusion
dence between the protein species being detected, we protein lures strongly suggests but does not prove that
first loaded 35S-labeled proteins affinity precipitated with these proteins interact with EBNA-LP in vivo in EBV-in-
MBP–W1W2Y1Y2 and GST–Sp1 on the same gel to ex- fected cells. To ascertain whether HSP binds to EBNA-
amine this relative mobility (Fig. 2A). The specifically in- LP in vivo, extracts from whole EBV-positive lymphoblas-
teracting species precisely comigrated. Several experi- toid cell lines BL36 and X50-7 were immunoprecipitated
ments were performed where one fusion protein was with monoclonal JF186 anti-EBNA-LP antibodies. Immu-
used to attempt to deplete the cell lysate of the inter- noprecipitates were blotted and probed for the presence
acting protein before affinity precipitation with the other of EBNA-LP and HSP73 (not shown). The HSP73 protein
fusion protein. These did not work. It proved very difficult coimmunoprecipitated with EBNA-LP from both cell lines.
to deplete the lysate using repeated (up to six) consecu- Anti-EBNA-LP antibodies used with EBV-negative cell ly-
tive precipitations with only one fusion. We suspected sates (not shown) or irrelevant murine monoclonal anti-
that the interacting species must not be a rare molecule bodies used with EBNA-LP containing cell lysates failed
but instead a relatively abundant cellular protein. to coprecipitate HSP73 (Fig. 4). In a cross-coprecipitation
analysis, lysates of BL36 were first immunoprecipitated
The proteins affinity precipitated by Sp1 and EBNA-
with EBNA-LP, HSP72/73, or Rb antisera and recovered
LP are HSP72/73
products run on polyacrylamide gel. Each precipitate was
then probed with anti-EBNA-LP and anti-HSP72/73 (Fig.Initially, nuclear lamins, about the same size as the
p68, were considered but anti-lamin B and anti-lamin A/ 4). EBNA-LP immunoprecipitates contained HSP72/73.
HSP72/73 immunoprecipitates contained EBNA-LP. RbC antibodies did not react with either the Sp1 or the
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LP in the cell is complexed with HSC. The EBNA-LP
immunoprecipitate contains 7.2% of the total EBNA-LP
and 0.1% of the HSC. Therefore, similarly, approximately
1.4% of the HSC in the cell is complexed with EBNA-LP.
EBNA-LP and Rb
EBNA-LP has been shown to colocalize in the nucleus
with Rb by in situ immunofluorescence and form com-
plexes with GST–Rb when that fusion protein is used as
a lure. When MBP–EBNA-LP fusions were used as a
lure we were unable to detect Rb in the affinity precipi-
tates from DG75 cell lysates (Fig. 5A). Under identical
conditions with the same lysates, GST–E1a, a fusion
protein containing the adenovirus E1a protein sequences
known to interact with Rb, was able to interact with Rb
and draw it into affinity precipitates. Reversing the lures,
and using GST–Rb to attract proteins from lysates of 293
cells (Ad 5 transformed human embryonic kidney cells
expressing E1a) or X50-7 (EBV-positive LCL), produced
similar results. GST–Rb interacted with the E1a in 293
cell lysates but not with EBNA-LP from X50-7 cell lysates.
The presence of the potentially interacting proteins in
the lysates was confirmed by immunoprecipitation with
FIG. 3. Domains required for EBNA-LP binding to HSP. In vitro bind-
ing assay consisting of amylose bead coated with MBP–EBNA-LP
fusions and purified soluble HSP73. (A) MBP and MBP fused to Wt
EBNA-LP with all four exons, W1, W2, Y1, and Y2. (B) Fusions containing
progressively fewer exons from the COOH end. (C) Fusions containing
progressively fewer exons from the NH2 end. A, B, and C were immu-
noblotted and probed with anti-HSP72/73. D, E, and F present the
Coomassie-stained acrylamide gels of fusion proteins recovered from
the loaded amylose beads. The diagram below the panel summarizes
the results.
immunoprecipitates contained HSP72/73 but not EBNA-
LP. The anti-Rb antibodies were used to coprecipitate
HSP73 with Rb, a finding which has been reported pre-
viously and was therefore used here as a positive control.
The EBNA-LP immunoprecipitate contained no detect-
able Rb (not shown) and the band near the position of
EBNA-LP in the Rb immunoprecipitate is but an intense
nonspecific band which appears as a containment in all
FIG. 4. Coimmunoprecipitation of EBNA-LP and HSP from EBV-posi-
the anti-Rb precipitates with this serum. Phosphorimages tive BL36 cells. Proteins were initially immunoprecipitated with antisera
of the blots shown in Fig. 4 were analyzed to estimate specific for EBNA-LP, HSP, or Rb and then immunoblotted and probed
with the same antisera. Rb immunoprecipitates contained two nonspe-the relative levels of protein present in the immunopre-
cific bands which always appeared regardless of which antiserumcipitates. The HSC immunoprecipitate contains 6.5% of
was used in the immunoblots. Lysates from 107 cells were used for
the total HSC and 1.7% of the total EBNA-LP. Therefore, immunoprecipitations and a control representing 106 cells solubilized
assuming that the immunoprecipitatable HSC is repre- in electrophesis sample buffer was run to indicate the position of the
specific protein bands.sentative of the total, approximately 25% of the EBNA-
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FIG. 5. Affinity precipitation of proteins by EBNA-LP, adenovirus, E1a, and Rb. (A) DG75 cell extracts were used with EBNA-LP and E1a fusion
proteins as lures followed by anti-Rb immunoblotting. (B) Adenovirus E1a expressing 293 cells were extracted and used with GST Rb as the lure
followed by anti-E1a immunoblotting. (C) EBNA-LP expressing X50-7 cells were used with GST–Rb as the lure followed by anti-EBNA-LP immunoblot-
ting. In B and C the left lane represents an immunoprecipitation of the E1a or EBNA-LP target protein with specific antisera. (D) In vitro affinity
interaction of MBP–EBNA-LP with GST–Rb with GST fusions attached to glutathione beads and MBP or MBP–EBNA-LP as the soluble target
proteins.
the appropriate antibody (Figs. 5B and 5C). Directed proteins react with JF186, a monoclonal antibody that
has its epitope in W1 where a putative Rb interactionMBP–EBNA-LP fusion protein and GST–Rb fusion pro-
domain is located. The positive controls demonstrate thattein interaction was performed in a cell-free buffer con-
other species are able to interact under the experimentalsisting of 20 mM Tris–Cl (pH 8.0), 100 mM NaCl, 0.5%
conditions employed.NP-40 (Fig. 5D). While neither GST nor GST–Rb inter-
acted with MBP, both GST and GST–Rb bound MBP–
EBNA-LP. This indicated that there was some affinity DISCUSSION
of the GST–Rb for the MBP–EBNA-LP fusion that was
dependent upon the EBNA-LP sequences; however, we The EBNA-LP protein represents a unique viral nuclear
were unable to show that the interaction detected re- oncogene. EBNA-LP is the first EBV gene product de-
quired the presence of Rb sequences. tected upon primary infection of resting B lymphocytes
We have sequenced the EBNA-LP ORF being used in (Allday et al., 1989). When the Y1 and Y2 exons are de-
leted from the viral genome, immortalization of B lympho-the above experiments and it is not mutated. The fusion
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cytes is debilitated but not entirely lost (Hammerschmidt several important physiological processes. They function
as molecular chaperones, transporting peptides and im-and Sugden, 1989). Several lines of evidence now sug-
gest that the protein plays a role in cell cycle control. mature proteins to cellular organelles and assisting in
protein folding to ensure proper conformation and sub-Cell cycle transition delays in arrested mutant immortal-
ized cells first suggested that EBNA-LP might function in unit organization (Palleros et al., 1991; Hightower, 1991;
Flynn et al., 1991). In the nucleus both Rb and p53 interactG1 (Allan et al., 1992). Recently, transfection of resting
cells with EBNA2 and EBNA-LP expressing plasmids has with HSPs and for p53 frequently the association is with
the mutant forms of this protein (Hinds et al., 1987). Itsuggested that the combination of these two proteins
along with CD21 crosslinking to mimic virus attachment is tempting to speculate that conformational changes,
perhaps influenced by cell-cycle-dependent phosphory-is able to lift resting cells out of G0 and into G1 (Sinclair
et al., 1994). lation, accompany protein–protein interaction during the
functioning of cell cycle regulators like Rb (Chen et al.,One therefore might suspect that a viral protein ex-
pressed early after infection, localized to the nucleus, 1989). HSPs may be involved in stabilizing complex for-
mation and/or in recharging spent regulators by facilitat-and involved in cell cycle control might function by inter-
acting with cellular growth control proteins. This has ing their return to an active conformation following de-
phosphorylation. In this way EBNA-LP may be similarlybeen a common theme among DNA tumor viruses that
are otherwise unrelated in genome structure or se- involved in transient complexes and undergo cell-cycle-
dependent conformational changes requiring or at leastquence (Whyte et al., 1988; Keen et al., 1994; Kaelin et
al., 1991). The targets for their immortalization and trans- influenced by HSPs.
formation genes include the antioncogene cell cycle reg-
ulators Rb and p53. It was therefore an interesting, but ACKNOWLEDGMENTS
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